CARDIFF ONCOLOGY, INC. Revenue, Net (Deprecated 2018-01-31)
CARDIFF ONCOLOGY, INC. (CRDF) reported Revenue, Net (Deprecated 2018-01-31) of $161.96 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2019-05-07
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2019-03-31 was $161.96K, a 61.74% increase year-over-year.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-12-31 was $78.02K, a 57.83% decline year-over-year.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $88.36K, a 28.35% decline year-over-year.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $111.81K, a 9.61% increase year-over-year.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for fiscal 2018 was $378.32K, a 25.14% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $505.40K, a 32.63% increase from fiscal 2016.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $381.07K, a 21.82% increase from fiscal 2015.
- CARDIFF ONCOLOGY, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $312.81K, a 11.65% increase from fiscal 2014.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 152 month | Revenue, Net (Deprecated 2018-01-31) 155 month | Revenue, Net (Deprecated 2018-01-31) 158 month | Revenue, Net (Deprecated 2018-01-31) 161 month | Revenue, Net (Deprecated 2018-01-31) 164 month | Revenue, Net (Deprecated 2018-01-31) 167 month | Revenue, Net (Deprecated 2018-01-31) 170 month | Revenue, Net (Deprecated 2018-01-31) 173 month | Revenue, Net (Deprecated 2018-01-31) 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $161.96K 10-Q · filed 2019-05-07 | $239.97K derived: sum of 2 quarters · filed 2019-05-07 | $328.33K derived: sum of 3 quarters · filed 2019-05-07 | $440.15K derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||
| 2018-12-31 | $78.02K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $166.38K derived: sum of 2 quarters · filed 2019-03-06 | $278.19K derived: sum of 3 quarters · filed 2019-03-06 | $378.32K 10-K · filed 2019-03-06 | ||||||||||
| 2018-09-30 | $88.36K 10-Q · filed 2018-11-07 | $200.17K derived: sum of 2 quarters · filed 2018-11-07 | $300.31K 10-Q · filed 2018-11-07 | $485.31K derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||
| 2018-06-30 | $111.81K 10-Q · filed 2018-08-03 | $211.95K 10-Q · filed 2018-08-03 | $396.95K derived: sum of 3 quarters · filed 2019-05-07 | $520.28K derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||
| 2018-03-31 | $100.14K 10-Q · filed 2019-05-07 | $285.14K derived: sum of 2 quarters · filed 2019-05-07 | $408.46K derived: sum of 3 quarters · filed 2019-05-07 | $510.48K derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||
| 2017-12-31 | $185.00K 10-K · filed 2018-02-26 | $308.33K derived: sum of 2 quarters · filed 2018-11-07 | $410.34K derived: sum of 3 quarters · filed 2018-11-07 | $505.40K 10-K · filed 2019-03-06 | ||||||||||
| 2017-09-30 | $123.33K 10-Q · filed 2018-11-07 | $225.34K derived: sum of 2 quarters · filed 2018-11-07 | $320.38K 10-Q · filed 2018-11-07 | $388.38K derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||
| 2017-06-30 | $102.01K 10-Q · filed 2018-08-03 | $197.05K 10-Q · filed 2018-08-03 | $265.05K derived: sum of 3 quarters · filed 2018-08-03 | $354.05K derived: sum of 4 quarters · filed 2018-08-03 | ||||||||||
| 2017-03-31 | $95.04K 10-Q · filed 2018-05-08 | $163.04K derived: sum of 2 quarters · filed 2018-05-08 | $252.04K derived: sum of 3 quarters · filed 2018-05-08 | $356.04K derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||
| 2016-12-31 | $68.00K 10-K · filed 2018-02-26 | $157.00K derived: sum of 2 quarters · filed 2018-02-26 | $261.00K derived: sum of 3 quarters · filed 2018-02-26 | $381.07K 10-K · filed 2018-02-26 | ||||||||||
| 2016-09-30 | $89.00K 10-K · filed 2018-02-26 | $89.11K 10-Q · filed 2016-11-09 | $193.00K derived: sum of 2 quarters · filed 2018-02-26 | $313.00K 10-Q · filed 2017-11-09 | $392.00K derived: sum of 4 quarters · filed 2018-02-26 | |||||||||
| 2016-06-30 | $104.00K 10-K · filed 2018-02-26 | $103.40K 10-Q · filed 2016-08-04 | $223.89K 10-Q · filed 2017-08-09 | $303.00K derived: sum of 3 quarters · filed 2018-02-26 | $361.00K derived: sum of 4 quarters · filed 2018-02-26 | |||||||||
| 2016-03-31 | $120.00K 10-K · filed 2018-02-26 | $120.49K 10-Q · filed 2016-05-10 | $199.00K derived: sum of 2 quarters · filed 2018-02-26 | $257.00K derived: sum of 3 quarters · filed 2018-02-26 | $306.00K derived: sum of 4 quarters · filed 2018-02-26 | |||||||||
| 2015-12-31 | $79.00K 10-K · filed 2017-03-15 | $137.00K derived: sum of 2 quarters · filed 2017-03-15 | $186.00K derived: sum of 3 quarters · filed 2017-03-15 | $312.81K 10-K · filed 2017-03-15 | ||||||||||
| 2015-09-30 | $58.00K 10-K · filed 2017-03-15 | $57.33K 10-Q · filed 2015-11-09 | $107.00K derived: sum of 2 quarters · filed 2017-03-15 | $233.64K 10-Q · filed 2016-11-09 | $290.00K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | $49.00K 10-K · filed 2017-03-15 | $49.35K 10-Q · filed 2015-08-10 | $176.32K 10-Q · filed 2016-08-04 | $232.00K derived: sum of 3 quarters · filed 2017-03-15 | $289.00K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | $127.00K 10-K · filed 2017-03-15 | $126.97K 10-Q · filed 2015-05-05 | $183.00K derived: sum of 2 quarters · filed 2017-03-15 | $240.00K derived: sum of 3 quarters · filed 2017-03-15 | $296.00K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | $56.00K 10-K · filed 2016-03-10 | $113.00K derived: sum of 2 quarters · filed 2016-03-10 | $169.00K derived: sum of 3 quarters · filed 2016-03-10 | $280.18K 10-K · filed 2017-03-15 | ||||||||||
| 2014-09-30 | $57.00K 10-K · filed 2016-03-10 | $57.20K 10-Q · filed 2014-11-06 | $113.00K derived: sum of 2 quarters · filed 2016-03-10 | $223.78K 10-Q · filed 2015-11-09 | $271.00K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | $56.00K 10-K · filed 2016-03-10 | $55.63K 10-Q · filed 2014-08-07 | $166.58K 10-Q · filed 2015-08-10 | $214.00K derived: sum of 3 quarters · filed 2016-03-10 | $258.00K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | $111.00K 10-K · filed 2016-03-10 | $110.95K 10-Q · filed 2014-05-12 | $158.00K derived: sum of 2 quarters · filed 2016-03-10 | $202.00K derived: sum of 3 quarters · filed 2016-03-10 | $251.00K derived: sum of 4 quarters · filed 2016-03-10 | $2.83M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | $47.00K 10-K · filed 2015-03-12 | $91.00K derived: sum of 2 quarters · filed 2015-03-12 | $140.00K derived: sum of 3 quarters · filed 2015-03-12 | $259.25K 10-K · filed 2016-03-10 | $2.72M 10-K · filed 2014-03-17 | |||||||||
| 2013-09-30 | $44.00K 10-K · filed 2015-03-12 | $43.76K 10-Q · filed 2013-11-14 | $93.00K derived: sum of 2 quarters · filed 2015-03-12 | $211.88K 10-Q · filed 2014-11-06 | $375.00K derived: sum of 4 quarters · filed 2015-03-12 | $2.67M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $49.00K 10-K · filed 2015-03-12 | $168.12K 10-Q · filed 2014-08-07 | $331.00K derived: sum of 3 quarters · filed 2015-03-12 | $543.00K derived: sum of 4 quarters · filed 2015-03-12 | $2.63M 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $119.00K 10-K · filed 2015-03-12 | $119.12K 10-Q · filed 2013-05-14 | $282.00K derived: sum of 2 quarters · filed 2015-03-12 | $494.00K derived: sum of 3 quarters · filed 2015-03-12 | $536.00K derived: sum of 4 quarters · filed 2015-03-12 | $2.58M 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | $163.00K 10-K · filed 2014-03-17 | $375.00K derived: sum of 2 quarters · filed 2014-03-17 | $417.00K derived: sum of 3 quarters · filed 2014-03-17 | $450.40K 10-K · filed 2015-03-12 | $2.46M 10-K · filed 2013-04-01 | |||||||||
| 2012-09-30 | $212.00K 10-K · filed 2014-03-17 | $211.50K 10-Q · filed 2012-11-14 | $254.00K derived: sum of 2 quarters · filed 2014-03-17 | $287.15K 10-Q · filed 2013-11-14 | $321.75K derived: sum of 4 quarters · filed 2014-03-17 | $2.30M 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | $42.00K 10-K · filed 2014-03-17 | $41.50K 10-Q · filed 2012-08-14 | $75.65K 10-Q · filed 2013-08-14 | $109.75K derived: sum of 3 quarters · filed 2014-03-17 | $164.75K derived: sum of 4 quarters · filed 2014-03-17 | $2.08M 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | $34.00K 10-K · filed 2014-03-17 | $34.15K 10-Q · filed 2012-05-15 | $67.75K derived: sum of 2 quarters · filed 2014-03-17 | $122.75K derived: sum of 3 quarters · filed 2014-03-17 | $202.61K derived: sum of 4 quarters · filed 2014-03-17 | $2.04M 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $33.75K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $88.75K derived: sum of 2 quarters · filed 2014-03-17 | $168.61K derived: sum of 3 quarters · filed 2014-03-17 | $257.70K 10-K · filed 2014-03-17 | ||||||||||
| 2011-09-30 | $55.00K 10-Q · filed 2012-11-14 | $134.86K derived: sum of 2 quarters · filed 2012-11-14 | $223.95K 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $79.86K 10-Q · filed 2012-08-14 | $168.95K 10-Q · filed 2012-08-14 | ||||||||||||
| 2011-03-31 | $89.08K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |